The U.S. Food and Drug Administration (FDA) has approved paforacyanin (Cytalux) as an injectable contrast agent for adults with lung cancer. of new approvalGranted following priority...
/cloudfront-us-east-1.images.arcpublishing.com/gray/2JMMERGTPJBUNL454BBSRGLKBM.bmp "Debilitating POTS in COVID-19 and rare vaccine-associated heart disease")
SOUTH BEND, Indiana (WNDU) – As the triple demic surges across the country, doctors want to warn of new, debilitating diseases linked to COVID infection and,...
This is a very common scenario and applies to nearly 92% of older people with cancer. An individual comes to treatment and reports that he is...
Researchers at the University of Illinois at Urbana-Champaign have discovered a way to generate a special class of molecules that can open the door to new...
Researchers at the University of Florida in the United States say the combination contains diphenhydramine, an antihistamine used for allergic symptoms. Two over-the-counter drugs have been...
Recent Comments